MARK2 and cancer: The function of PIM2 in cancer depends on its serine/threonine kinase activity, which can phosphorylate multiple substrates including p21, p27, NOTCH1, p65, BAD, AMPKα1, TSC2, PKM2, c-MYC, HK2 and HSF1 12, 14-18.